SKIN Beauty Health Company
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): May 5, 2021
THE BEAUTY HEALTH COMPANY
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
2165 Spring Street
Long Beach, CA
|(Address of principal executive offices)||(Zip Code)|
(Registrant’s telephone number, including area code)
Vesper Healthcare Acquisition Corp.
1818 West Avenue, Bay 2
Miami Beach, FL 33139
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange on which registered
Units, each consisting of one share of
Class A Common Stock and one-
third of one Redeemable Warrant
|VSPRU||The Nasdaq Stock Market LLC|
Class A Common Stock, par value
$0.0001 per share
|VSPR||The Nasdaq Stock Market LLC|
Warrants, each exercisable for one
share of Class A Common Stock at a
price of $11.50
|VSPRW||The Nasdaq Stock Market LLC|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Regulation FD Disclosure.
On May 5, 2021, The Beauty Health Company f/k/a Vesper Healthcare Acquisition Corp. issued a press release announcing the consummation of its business combination with LCP Edge Intermediate, Inc., a Delaware corporation and indirect parent of Edge Systems LLC d/b/a The HydraFacial Company. A copy of the press release is furnished herewith as Exhibit 99.1.
The information in this Item 7.01 and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.
Financial Statements and Exhibits.
|99.1||Press Release, dated May 5, 2021.|
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|The Beauty Health Company|
|Dated: May 5, 2021||By:||/s/ Clinton E. Carnell|
|Name: Clinton E. Carnell|
|Title: Chief Executive Officer|